NASDAQ:TNXP - Tonix Pharmaceuticals Stock Price, Forecast & News

Tonix Pharmaceuticals trades on the NASDAQ under the ticker symbol "TNXP."

Shares of Tonix Pharmaceuticals reverse split before market open on Wednesday, November 28th 2018. The 1-10 reverse split was announced on Tuesday, November 27th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, November 27th 2018. An investor that had 100 shares of Tonix Pharmaceuticals stock prior to the reverse split would have 10 shares after the split.

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) posted its earnings results on Friday, November, 8th. The company reported ($5.69) EPS for the quarter, missing the Zacks' consensus estimate of ($4.35) by $1.34. View Tonix Pharmaceuticals' Earnings History.

Tonix Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Tonix Pharmaceuticals.

1 Wall Street analysts have issued 1-year target prices for Tonix Pharmaceuticals' shares. Their forecasts range from $1.30 to $1.30. On average, they anticipate Tonix Pharmaceuticals' share price to reach $1.30 in the next twelve months. This suggests that the stock has a possible downside of 20.2%. View Analyst Price Targets for Tonix Pharmaceuticals.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tonix Pharmaceuticals in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tonix Pharmaceuticals.

Media coverage about TNXP stock has trended extremely negative this week, according to InfoTrie. The research group identifies positive and negative media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Tonix Pharmaceuticals earned a coverage optimism score of -4.5 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Tonix Pharmaceuticals.

Tonix Pharmaceuticals saw a drop in short interest during the month of January. As of January 15th, there was short interest totalling 103,200 shares, a drop of 66.6% from the December 31st total of 309,300 shares. Based on an average daily volume of 1,510,000 shares, the days-to-cover ratio is presently 0.1 days. Currently, 1.2% of the company's shares are short sold. View Tonix Pharmaceuticals' Current Options Chain.

Some companies that are related to Tonix Pharmaceuticals include Seelos Therapeutics (SEEL), Spring Bank Pharmaceuticals (SBPH), Innovate Biopharmaceuticals (INNT), Unum Therapeutics (UMRX), Pulmatrix (PULM), Vistagen Therapeutics (VTGN), Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (ZOM), Aptevo Therapeutics (APVO), Generex Biotechnology (GNBT), Addex Therapeutics (ADDXF), Akari Therapeutics (AKTX), Fibrocell Science (FCSC), AzurRx BioPharma (AZRX), VIVUS (VVUS) and Bellerophon Therapeutics (BLPH).

Based on aggregate information from My MarketBeat watchlists, some companies that other Tonix Pharmaceuticals investors own include Rite Aid (RAD), Inovio Pharmaceuticals (INO), SCYNEXIS (SCYX), Novavax (NVAX), Actinium Pharmaceuticals (ATNM), Opko Health (OPK), Sorrento Therapeutics (SRNE), Synthetic Biologics (SYN), Anavex Life Sciences (AVXL) and T2 Biosystems (TTOO).

Shares of TNXP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of TNXP stock can currently be purchased for approximately $1.63.

Tonix Pharmaceuticals has a market capitalization of $10.12 million. The company earns $-26,090,000.00 in net income (profit) each year or ($268.10) on an earnings per share basis. Tonix Pharmaceuticals employs 12 workers across the globe.View Additional Information About Tonix Pharmaceuticals.

The official website for Tonix Pharmaceuticals is http://www.tonixpharma.com/.

Tonix Pharmaceuticals' mailing address is 509 MADISON AVENUE SUITE 1608, NEW YORK NY, 10022. The company can be reached via phone at 212-980-9155 or via email at [email protected]